Hilary T Chute

This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Amgen Inc., Medarex Inc., E. R. Squibb Sons, Inc.. Active years: 2008-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hilary T Chute. Retrieved from https://idiyas.com/inventor/hilary-t-chute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 60.0

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 31(Granted Patents)

Company Filing History:

E. R. Squibb Sons, Inc.

patents

where one patent can have more than one assignee

Years Active: 2008-2014

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8906371 - Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors (2014-12-09),

2. 8529893 - Methods for treating IFN-γ mediated diseases using human anti-IFN-γ neutralizing antibodies as selective IFN-gamma pathway inhibitors (2013-09-10),

3. 8202976 - Nucleic acid molecules that encode human anti-IFN-gamma neutralizing antibodies as selective IFN-gamma pathway inhibitors (2012-06-19),

4. 7790859 - Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors (2010-09-07),

5. 7335743 - Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors (2008-02-26),

Title: The Innovations of Hilary T Chute

Introduction

Hilary T Chute is a prominent inventor based in Calabasas, CA. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 5 patents, his work has the potential to impact the treatment of various diseases.

Latest Patents

One of his latest patents is titled "Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors." This invention provides antibodies that interact with or bind to human interferon-gamma (IFN-γ) and outlines methods for treating IFN-γ mediated diseases. The patent also includes methods for detecting the amount of IFN-γ in a sample using these antibodies. Another patent with similar focus emphasizes the therapeutic applications of human anti-IFN-γ neutralizing antibodies.

Career Highlights

Throughout his career, Hilary T Chute has worked with notable companies such as Amgen Inc. and Medarex Inc. His experience in these organizations has contributed to his expertise in the field of biotechnology and antibody development.

Collaborations

Hilary has collaborated with esteemed colleagues, including Andrew A Welcher and Haichun Huang. These partnerships have likely enhanced his research and innovation capabilities.

Conclusion

Hilary T Chute's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.